Focus Biomolecules will be exhibiting at the annual meeting of the American Society for Biochemistry and Molecular Biology near Washington, DC, March 7 – 10. Stop
FOCUS on new drug approvals. On February 24th the FDA granted approval to Encorafenib (Braftovi, Array Biopharma, a subsidiary of Pfizer) in combination with cetuximab and
Will you be attending the AACR (American Association for Cancer Research) Annual Meeting 2026 in San Diego this April? Focus Biomolecules will be awarding two travel
FOCUS on new drug approvals. On February 12th the FDA granted approval for Acrotech Biopharma’s Difamilast (Adquey) for mild to moderate atopic dermatitis. The approval marks
FOCUS on Drug Repurposing. A study just published in Neuron suggests the HIV drug Maraviroc (a CCR5 antagonist) may be useful for the treatment of glioblastoma
FOCUS on Parkinson’s Disease: Y Xu and coworkers identified deubiquitinating enzyme USP25 as a susceptible locus for PD as just reported in PNAS. They showed that USP25
BOGO
